LISA MERCADO: Open Payments
NPI 1770181182 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 26 payments from 8 companies in 2025. Trend: 2023 $1,172 · 2024 $449 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $140 |
| Neurocrine BioSciences, Inc. | 4 | $126 |
| Vanda Pharmaceuticals Inc. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lilly USA, LLC | 2 | $55 |
| UCB, Inc. | 2 | $52 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Ardelyx, Inc. | 1 | $27 |
Products named: AUSTEDO XR, INGREZZA, FANAPT, REXULTI, AMYVID, Auvelity, IBSRELA, Nayzilam.
Industry payments across FL — which companies pay providers there.
